Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Topp, Max S
[Clear All Filters]
2024
Werner R
,
Haug A
,
Buske C
,
Heidegger S
,
Illert AL
,
Bassermann F
,
Herhaus P
,
Buck A
,
Duell J
,
Topp MS
, et al.
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Nuklearmedizin. 2024.
PubMed
Google Scholar
2023
Fuchs M
,
Jacob ASophie
,
Kaul H
,
Kobe C
,
Kuhnert G
,
Pabst T
,
Greil R
,
Bröckelmann PJ
,
Topp MS
,
Just M
, et al.
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
Leukemia. 2023.
PubMed
Google Scholar
Gökbuget N
,
Ihrig K
,
Stadler M
,
Stelljes M
,
Elmaagli A
,
Starck M
,
Raffel S
,
Stoltefuss A
,
Viardot A
,
Kreuzer K-A
, et al.
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia.
Haematologica. 2023.
PubMed
Google Scholar
Shah BD
,
Cassaday RD
,
Park JH
,
Houot R
,
Oluwole OO
,
Logan AC
,
Boissel N
,
Leguay T
,
Bishop MR
,
Topp MS
, et al.
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
J Immunother Cancer. 2023;11(8).
PubMed
Google Scholar
2022
Bethge WAndreas
,
Martus P
,
Schmitt M
,
Holtick U
,
Subklewe M
,
von Tresckow B
,
Ayuk F
,
Wagner-Drouet EMaria
,
Wulf GG
,
Marks R
, et al.
GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany.
Blood. 2022.
PubMed
Google Scholar
Eichenauer DA
,
Bühnen I
,
Plütschow A
,
Kobe C
,
Dietlein M
,
Wendtner C-M
,
Thorspecken S
,
Topp MS
,
Mauser M
,
von Tresckow B
, et al.
Phase II study of fixed-duration single-agent ibrutinib in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Hematol Oncol. 2022.
PubMed
Google Scholar
2021
Topp MS
,
Stein AS
,
Gökbuget N
,
Horst H-A
,
Boissel N
,
Martinelli G
,
Kantarjian H
,
Brüggemann M
,
Chen Y
,
Zugmaier G
.
Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia: Results of a pooled analysis.
Cancer Med. 2021.
PubMed
Google Scholar
Gillessen S
,
Plütschow A
,
Fuchs M
,
Markova J
,
Greil R
,
Topp MS
,
Meissner J
,
Zijlstra JM
,
Eichenauer DA
,
Bröckelmann PJ
, et al.
Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Lancet Haematol. 2021;8(4):e278-e288.
PubMed
Google Scholar
Shah BD
,
Ghobadi A
,
Oluwole OO
,
Logan AC
,
Boissel N
,
Cassaday RD
,
Leguay T
,
Bishop MR
,
Topp MS
,
Tzachanis D
, et al.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet. 2021.
PubMed
Google Scholar
Borchmann P
,
Plütschow A
,
Kobe C
,
Greil R
,
Meissner J
,
Topp MS
,
Ostermann H
,
Dierlamm J
,
Mohm J
,
Thiemer J
, et al.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol. 2021;22(2):223-234.
PubMed
Google Scholar
2020
Topp MS
,
Gökbuget N
,
Zugmaier G
,
Stein AS
,
Dombret H
,
Chen Y
,
Ribera J-M
,
Bargou RC
,
Horst H-A
,
Kantarjian HM
.
Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
Cancer. 2020.
PubMed
Google Scholar
2019
Stein AS
,
Kantarjian H
,
Gökbuget N
,
Bargou R
,
Litzow MR
,
Rambaldi A
,
Ribera J-M
,
Zhang A
,
Zimmerman Z
,
Zugmaier G
, et al.
Blinatumomab for Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar
Jabbour EJ
,
Gökbuget N
,
Kantarjian HM
,
Thomas X
,
Larson RA
,
Yoon S-S
,
Ghobadi A
,
Topp MS
,
Tran Q
,
Franklin JL
, et al.
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study.
Cancer. 2019.
PubMed
Google Scholar